More than a Movement Disorder: Applying Palliative Care to Parkinson's Disease
不仅仅是运动障碍:对帕金森病进行姑息治疗
基本信息
- 批准号:9175308
- 负责人:
- 金额:$ 58.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-15 至 2021-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdoptionAdultAdvance Care PlanningAffectAgeAmericanAssessment toolCancer PatientCaregiver BurdenCaregiversCaringCause of DeathCharacteristicsChronicChronic DiseaseCommunitiesDataDementiaDiseaseDisease modelDistressEffectivenessElderlyEmergency department visitFamilyFamily CaregiverFatigueFoundationsFundingFutureGoalsHealthHealth Care CostsHeart failureHigh PrevalenceHip FracturesHome environmentHospitalizationIndividualInterventionInterviewLifeLinear RegressionsLung diseasesMaintenanceMalignant NeoplasmsMental DepressionMethodsModelingMoodsMovement DisordersNeeds AssessmentNeurodegenerative DisordersNeurologistNeurologyNursing HomesOutcomeOutcomes ResearchOutpatientsPainPalliative CareParkinson DiseaseParticipantPatient-Focused OutcomesPatientsPersonsPopulationPragmatic clinical trialPrimary Care PhysicianProgressive DiseaseProviderPsychosocial InfluencesQuality of lifeRandomized Clinical TrialsResearchResearch InstituteResearch PersonnelResourcesServicesSiteSocial Health ServicesSpecialistSurveysSymptomsSystemTechniquesTelemedicineTrainingTremorUnited StatesWorkabstractingbasecostdesigndisabilitydissemination trialempoweredhealth care service utilizationhigh riskimprovedimproved outcomeinformal caregiverinnovationmeetingsmembermortalitymotor symptommultidisciplinarynon-motor symptomnovelpalliativephysical symptomprimary outcomepsychiatric symptomrandomized trialsecondary outcomeservice utilizationsocialtime usetreatment as usualtreatment effecttrial design
项目摘要
Project Summary/Abstract: Parkinson's disease (PD) is the second most common neurodegenerative illness
affecting approximately 1.5 million Americans and is the 14th leading cause of death in the United States. PD is
traditionally described as a movement disorder with characteristic motor symptoms (e.g. tremor). However,
more recent research demonstrates the impact of nonmotor symptoms such as pain, depression, and
dementia on mortality, quality of life (QOL), nursing home placement and caregiver distress. Regarding models
of care for PD, evidence suggests that care including a neurologist results in lower mortality and nursing home
placement than care solely from a primary care physician. Unfortunately, there is also significant evidence that
many of the needs most important to PD patients and their caregivers (e.g. depression, planning for the future)
are poorly addressed under current models of care. Palliative care is an approach to caring for individuals with
life-threatening illnesses that focuses on addressing potential causes of suffering including physical and
psychiatric symptoms, psychosocial issues and spiritual needs. While developed for cancer patients, palliative
care approaches have been successfully applied in other chronic progressive illnesses including heart failure
and pulmonary disease. To date there have been minimal attempts to apply these principles to PD although
evidence suggests that PD patients' unmet needs under current models of care may be amenable to palliative
care. A small but growing cadre of centers offer outpatient palliative care for PD with early evidence of efficacy
and a randomized trial of an academic-based outpatient palliative care is underway led by investigators on this
proposal. While this work is critical to forwarding this field, further work is needed to provide a model that can
be widely disseminated. The current proposal addresses this gap by assessing the effectiveness and feasibility
of a novel community-based intervention that empowers community neurology practices to improve care for
PD patients and caregivers through palliative care training, coaching and telemedicine resources. We
hypothesize that this intervention will improve patient QOL and caregiver burden and will prove feasible and
acceptable to community providers. Our Specific Aims are to: 1) Determine the a) effectiveness and b)
feasibility of a novel community-based outpatient palliative care intervention for PD.; 2) Describe the effects of
a this intervention on patient and caregiver costs and service utilization; and 3) Identify opportunities to
optimize community-based palliative care for this population by: a) describing patient and caregiver
characteristics associated with intervention benefits; and b) through direct patient, caregiver and provider
interviews. Innovations of our approach include a novel model of providing disease-specific community-based
palliative care not dependent on limited palliative specialist resources, a stepped-wedge trial design and use of
telemedicine resources to provide multidisciplinary care. The research is significant because it will create a
foundation for future community-based dissemination studies in PD and the broader field of palliative care.
项目概要/摘要:帕金森病(PD)是第二常见的神经退行性疾病
影响了大约150万美国人,是美国第14大死亡原因。PD是
传统上被描述为具有特征性运动症状(例如震颤)的运动障碍。然而,在这方面,
最近的研究表明,非运动症状,如疼痛,抑郁,
痴呆症对死亡率、生活质量(QOL)、疗养院安置和照顾者痛苦的影响。关于模型
有证据表明,包括神经科医生在内的护理可降低死亡率,
而不是仅仅从初级保健医生那里得到护理。不幸的是,也有重要证据表明,
对PD患者及其护理人员最重要的许多需求(例如抑郁、规划未来)
在目前的护理模式下,这些问题得不到很好的解决。姑息治疗是一种照顾患有
危及生命的疾病,重点是解决痛苦的潜在原因,包括身体和
精神症状、社会心理问题和精神需求。虽然是为癌症患者开发的,
护理方法已成功应用于其他慢性进展性疾病,包括心力衰竭,
和肺部疾病。迄今为止,将这些原则应用于PD的尝试很少,
有证据表明,PD患者在当前护理模式下未满足的需求可能适合姑息治疗,
在乎一个规模虽小但不断壮大的中心为PD提供门诊姑息治疗,并有早期疗效证据
一项基于学术的门诊姑息治疗的随机试验正在进行中,
提议虽然这项工作对于推进这一领域至关重要,但还需要进一步的工作来提供一个模型,
广泛传播。目前的建议通过评估有效性和可行性来弥补这一差距。
一种新的基于社区的干预,使社区神经病学的做法,以改善护理
通过姑息治疗培训、指导和远程医疗资源,帮助PD患者和护理人员。我们
假设该干预措施将改善患者QOL和护理人员负担,并将证明是可行的,
社区供应商可以接受。我们的具体目标是:1)确定a)有效性和B)
一种新的以社区为基础的PD门诊姑息治疗干预的可行性。2)描述的影响
a)对患者和护理人员的成本和服务利用进行干预;以及3)确定机会,
通过以下方式优化这一人群的社区姑息治疗:a)描述患者和护理人员
与干预益处相关的特征;以及B)通过直接患者、护理者和提供者
采访我们方法的创新包括一种新的模式,
姑息治疗不依赖于有限的姑息治疗专家资源,一个阶梯楔形试验设计和使用
远程医疗资源,以提供多学科护理。这项研究意义重大,因为它将创造一个
为未来PD和更广泛的姑息治疗领域的社区传播研究奠定了基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BENZI M KLUGER其他文献
BENZI M KLUGER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BENZI M KLUGER', 18)}}的其他基金
Developing a Prediction Model to Improve End‐of‐Life Prognostication and Hospice Referral in Parkinson's Disease
开发预测模型以改善帕金森病的临终预测和临终关怀转诊
- 批准号:
10524354 - 财政年份:2022
- 资助金额:
$ 58.32万 - 项目类别:
Advancing Palliative Care for Older Adults Affected by Neurodegenerative Disease: Parkinsons disease, Alzheimers disease and Related Dementias
推进对受神经退行性疾病影响的老年人的姑息治疗:帕金森病、阿尔茨海默病和相关痴呆症
- 批准号:
10468798 - 财政年份:2020
- 资助金额:
$ 58.32万 - 项目类别:
Advancing Palliative Care for Older Adults Affected by Neurodegenerative Disease: Parkinsons disease, Alzheimers disease and Related Dementias
推进对受神经退行性疾病影响的老年人的姑息治疗:帕金森病、阿尔茨海默病和相关痴呆症
- 批准号:
10055394 - 财政年份:2020
- 资助金额:
$ 58.32万 - 项目类别:
Advancing Palliative Care for Older Adults Affected by Neurodegenerative Disease: Parkinsons disease, Alzheimers disease and Related Dementias
推进对受神经退行性疾病影响的老年人的姑息治疗:帕金森病、阿尔茨海默病和相关痴呆症
- 批准号:
10264138 - 财政年份:2020
- 资助金额:
$ 58.32万 - 项目类别:
More than a Movement Disorder: Applying Palliative Care to Parkinson's Disease and Lewy Body Dementias
不仅仅是运动障碍:对帕金森病和路易体痴呆症进行姑息治疗
- 批准号:
10657697 - 财政年份:2016
- 资助金额:
$ 58.32万 - 项目类别:
More than a Movement Disorder: Applying Palliative Care to Parkinson's Disease and Lewy Body Dementias
不仅仅是运动障碍:对帕金森病和路易体痴呆症进行姑息治疗
- 批准号:
10298020 - 财政年份:2016
- 资助金额:
$ 58.32万 - 项目类别:
Finding the Ethical Path Forward: A Bioethical and Stakeholder-driven Investigation on the Sharing of Palliative-related Survey Results with Patients, Caregivers and Community Clinicians
寻找前进的道德道路:关于与患者、护理人员和社区临床医生共享姑息治疗相关调查结果的生物伦理和利益相关者驱动的调查
- 批准号:
10790789 - 财政年份:2016
- 资助金额:
$ 58.32万 - 项目类别:
Characterizing Intrinsic Functional Cortical Networks in Parkinson Disease Dementia
帕金森病痴呆的内在功能皮质网络特征
- 批准号:
9111686 - 财政年份:2016
- 资助金额:
$ 58.32万 - 项目类别:
Intrinsic Cortical Networks and Cognitive Dysfunction in Parkinson's Disease
帕金森病的内在皮质网络和认知功能障碍
- 批准号:
9084675 - 财政年份:2013
- 资助金额:
$ 58.32万 - 项目类别:
Intrinsic Cortical Networks and Cognitive Dysfunction in Parkinson???s Disease
帕金森病的内在皮质网络和认知功能障碍
- 批准号:
8635587 - 财政年份:2013
- 资助金额:
$ 58.32万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 58.32万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 58.32万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 58.32万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 58.32万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 58.32万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 58.32万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 58.32万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 58.32万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 58.32万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 58.32万 - 项目类别:
Research Grant














{{item.name}}会员




